Cholesterol Screening Market Projected to Reach US$ 17.5 Billion by 2021| Global Major Manufacturers, Production and Sales Market Comparison

ReportsnReports always aims at offering their clients an in-depth analysis and the best research material of the various market. This report on the global Cholesterol Screening Market is committed fulfilling the requirements of the clients by giving them thorough insights into the market. An exclusive data offered in this report is collected by research and industry experts team. Cholesterol Screening Market market spread across 139 Pages, profiling 10 companies and supported with tables and figures.

Download Free Sample Copy of “Cholesterol Screening Market” at https://www.reportsnreports.com/contacts/requestsample.aspx?name=832600

The Global Cholesterol Testing Services Market is expected to reach US$ 17.5 Billion by 2021 from US$ 11.9 Billion in 2016, growing at a CAGR of 8% during the forecast period. This market is segmented on the basis of type of customer and region. Based on type of customer, the market is segmented into physicians/providers and hospitals; employers, health plans, and Managed Care Organizations (MCOs); government agencies, Accountable Care Organizations (ACOs), and Integrated Delivery Networks (IDNs); and patients. Based on region, the cholesterol testing services market is segmented into North America, Europe, Asia, and the Rest of the World (RoW).

Factors such as increasing incidence of cardiovascular diseases and obesity, physician preference of laboratory testing rather self-testing, growing awareness and adoption of preventive healthcare, government initiatives to improve the quality of testing, and rapid growth in the geriatric population are propelling the growth of this market.

North America is estimated to account for the largest share of the global cholesterol testing services market. In North America, the U.S. is a major market for cholesterol testing service providers. North America’s dominance in the market can be attributed to the increase in Clinical Laboratory Improvement Amendments (CLIA) waivers for certain diagnostic tests (including blood cholesterol), growing geriatric population, increasing efforts by ACOs for population health management and early disease intervention, and the presence of leading market players in the region.

Research Coverage:
Apart from comprehensive geographical analysis, service analysis, and market sizing, the report also provides cost structure & pricing analysis, reimbursement scenario, market share analysis and competitive landscape that cover growth strategies adopted by industry players in the last three years. Also, the company profiles comprise basic views on the key players and their product portfolios, core competencies, developments, and strategies adopted.

#Top Key Players in the “Cholesterol Screening Market” include are Laboratory Corporation of America Holdings (Labcorp),Quest Diagnostics Incorporated,Eurofins Scientific,Spectra Laboratories, Inc.,Unilabs,Synlab International GmbH,Bio-Reference Laboratories, Inc.,Clinical Reference Laboratory, Inc.,ACM Medical Laboratory),Adicon Clinical Laboratory.

A Discount (Up to 25%) can be asked before order a copy of Cholesterol Screening Market report at https://www.reportsnreports.com/contacts/discount.aspx?name=832600

#Target Audience/ Stakeholders for Cholesterol Screening Market: Cholesterol Testing Service Providers,Cholesterol Testing Kit Manufacturers,Public and Private Physicians,Healthcare Institutions (Medical Data Centers),Diagnostic & Clinical Laboratories,Distributors and Suppliers of Cholesterol Testing Kits,Health Insurance Companies/Payers,Pharmaceutical Companies,Employers/Organizations,Market Research and Consulting Firms.

About Us:-
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India

This release was published on openPR.